The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we ...

Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...